KY AG: Anti-drug program is a success ...

Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, has extended the duration of the expanded ...

The labeling updates address the risk of early-onset toxicity, including life-threatening adverse events in patients with DPD ...

Pfizer Inc. (NYSE: PFE) today announced the launch of its program on TrumpRxextlink label, making innovative medicines more affordable and accessible ...

The controversy over President Donald Trump's now-deleted post with an AI-generated video depicting the Obamas as apes was ...

Energy Star, the program that helps guide consumers to more energy-efficient appliances and electronics, has survived President Donald Trump’s attempt to kill it ...

A part-time courtesy clerk at the North Division Rosauers placed third in the country during a Feb. 2 grocery bagging ...

Allschwil, Switzerland - February 06, 2026Idorsia Ltd (SIX: IDIA) announces the design of its FDA-agreed Phase 3 registration program for lucerastat in Fabry disease. Building on the robust biomarker ...

Two members of Simon Fraser University’s Faculty of Communication, Art and Technology have been honoured as members of the ...

Designed to reinforce lucerastat as the first oral therapy suitable for all patients with Fabry disease, irrespective of their mutation type. The program is expected to support a potential regulatory ...

There is a reason power is in the name of loyalty shoppers for Natural Grocers by Vitamin Cottage. Actions by \{N\}Power ...

Culture Watch is a series spotlighting the intersection of fashion and art, bringing you the latest must-see exhibitions, pop ...